Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for post-burn itch
NL-OMON31113Not yet recruiting
- Sponsor
- Martini Ziekenhuis
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of naltrexone in pruritus and burn injury (2 arms), sponsored by Martini Ziekenhuis. Primary endpoints: Mean itch intensity score at endpoint and Percentage change in itch intensity score from baseline. Planned start Aug 2007; status: not yet recruiting.
02
Drugs
naltrexone
03
Conditions
pruritusburn injury
Beyond the preview
Go deeper on NL-OMON31113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31113.